SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe Stephenson who wrote (78)2/13/1997 9:52:00 PM
From: Donald Gravenor   of 1321
 
Here's the scenario:
A patient with advanced, inoperable (or progressive) lung cancer has an obstruction of his main stem bronchus. He's already recieved as much radiation as he can get, and is now short of breath. You can try to burn out the tumor with a yag laser, or use photofrin. The only problem here is that it virtually doesn't matter. The patients' life expectancy is measured in weeks, not months. No intervention at this point matters.
This being said, I think that photofrin will develop a nitche, here.
The stock is undoubtedly moving because of this indication. I just dont think that this use of the drug will get the stock very far in the long run.
Incidently, I'm long about 1,000 shares, now.
DG
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News